Completed OBSERVATIONAL NCT01326624

Study of the Wearable Defibrillator in Heart-Failure Patients (SWIFT)

Study of the Wearable Defibrillator In Heart-Failure Patients

Sponsor: Zoll Medical Corporation

Conditions Heart Failure Sudden Cardiac Arrest Sudden Death Ventricular Dysfunction Ventricular Fibrillation Ventricular Tachycardia

Interventions wearable defibrillator (LifeVest)

Updated 9 times since 2017 Last updated: Dec 4, 2017 Started: Mar 31, 2011 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Heart Failure and Sudden Cardiac Arrest and is currently completed. Zoll Medical Corporation leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 4 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Dec 2017 — Apr 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Feb 2017 — Dec 2017 [monthly]

Active Not Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting NA

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zoll Medical Corporation

Data source: Zoll Medical Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States
• Tel Litwinsky, Israel